Forte Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.9% | +14.5% | +114.0% | -98.2% | +390.9% | -33.3% | -100.0% | – | +333.3% | +64.1% | |
| – | – | – | +54.3% | -99.5% | +2,577.1% | +340.8% | -4.7% | -18.2% | -5.8% | +102.2% | |
| – | – | – | – | -78.9% | +88,347.2% | -86.6% | – | – | – | – | |
| – | +150.3% | +34.7% | +141.3% | -79.4% | -406.2% | – | +133.2% | -123.3% | – | +547.2% | |
| – | +127.3% | +24.8% | +200.5% | -91.8% | -100.0% | – | -100.0% | – | -58.0% | +213.5% | |
| – | – | -212.8% | -84.9% | -96.1% | – | – | – | – | -76,680.9% | – | |
| – | -89.8% | -97.4% | +32,328.1% | -71.4% | – | – | – | – | +1,566.7% | -100.0% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -95.3% | +3,727.7% | -51.2% | -88.8% | +1,272.9% | -100.1% | – | +240.9% | +110.1% | +33.8% | |
| – | -166.9% | – | -84.0% | -794.1% | – | -132.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – |
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.